Lost password ?
<< Back to Equity Research
Mouwasat Medical
MOUWASAT MEDICAL, A HEALTHY GROWTH STORY BUT EXPENSIVE
Apr 29 - After a slide of three continuous months, Mouwasat (Sell, Saudi Arabia) skyrocketed by 44.7% over the last six months, of which 20.8% YTD. Investors were likely worried about the growth deceleration ...
Executive summary
Conflict of Interest
Pages 39
Language English
Publish on April 29, 2024
€ 500
VAT Exl.
You might be also interested by these reports :
May 14 PM
Mouwasat Medical
Weaker-than-expected Q1 but nothing worrying
May 14 AM
Dallah Healthcare
Weaker-than-expected revenue but a strong net result
Apr 29 PM
Idea Kicker
MOUWASAT MEDICAL, A HEALTHY GROWTH STORY BUT EXPE...
Apr 08 AM
Mouwasat Medical
Target pushed up by strong results
FIND A REPORT
CONCEPT
Each company is researched in depth using a structured robust and transparent process.

AlphaMena provides analyses based upon exhaustive and homogeneous information which allows to compare stocks geographically, sector-wise, and by thematic.

The analyses include actuarial as well as off balance-sheet data.
BloombergStarmineFactsetReutersCapital IQ